Enanta Pharma loses appeal in Pfizer Paxlovid patent case
Go back to Enanta Pharma loses appeal in Pfizer Paxlovid patent case| ENANTA PHARM (NASDAQ: ENTA) | Delayed: 13.50 -0.58 (4.12%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $14.08 | 52 Week High | $34.49 | |||
| Open | $13.91 | 52 Week Low | $20.39 | |||
| Day High | $13.91 | P/E | N/A | |||
| Day Low | $13.43 | EPS | $-3.18 | |||
| Volume | 158,196 | |||||
| Pfizer Inc. (NYSE: PFE) | Delayed: 27.79 -0.66 (2.32%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $28.45 | 52 Week High | $37.39 | |||
| Open | $28.01 | 52 Week Low | $28.25 | |||
| Day High | $28.15 | P/E | 16.84 | |||
| Day Low | $27.72 | EPS | $1.65 | |||
| Volume | 31,756,884 | |||||
